UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Implications of SARS-CoV-2 genetic diversity and mutations on pathogenicity of the COVID-19 and biomedical interventions

Journal of Taibah University Medical Sciences, 2020-08, Vol.15 (4), p.258-264

2020

Volltextzugriff (PDF)

P667: LONG‐TERM EFFICACY OF ACALABRUTINIB‐BASED REGIMENS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND HIGHER‐RISK GENOMIC FEATURES: POOLED ANALYSIS OF CLINICAL TRIAL DATA

HemaSphere, 2022-06, Vol.6, p.565-566

2022

Volltextzugriff (PDF)

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours

British journal of cancer, 2012-05, Vol.106 (11), p.1728-1734

2012

Volltextzugriff (PDF)

Type 1 diabetes mellitus and enterovirus linkage: search for associated etiopathology

The Egyptian journal of internal medicine, 2017-07, Vol.29 (3), p.93-99

2017

Volltextzugriff (PDF)

The interplay between environmental factors, vector competence and vaccine immunodynamics as possible explanation of the 2019 yellow fever re-emergence in Nigeria

New microbes and new infections, 2021-05, Vol.41, p.100858, Article 100858

2021

Volltextzugriff (PDF)

NXY-059 for the Treatment of Acute Ischemic Stroke

The New England journal of medicine, 2007-08, Vol.357 (6), p.562-571

2007

Volltextzugriff (PDF)

1748P 4-factor model to predict response and survival benefit with durvalumab (D) in previously treated metastatic urinary tract carcinoma (mUTC)

Annals of oncology, 2022-09, Vol.33, p.S1337

2022

Volltextzugriff (PDF)

P4.11D.01 TRITON: Tremelimumab + Durvalumab + Chemotherapy (CT) vs Pembrolizumab + CT in mNSCLC with STK11, KEAP1 and/or KRAS Mutations

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S389-S389

2024

Volltextzugriff (PDF)

P1.01-108 PACIFIC-6: A Phase II Study of Durvalumab Following Sequential Chemoradiotherapy in Patients with Stage III, Unresectable NSCLC

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S403-S404

2019

Volltextzugriff (PDF)

NXY-059 for the Treatment of Acute Stroke : Pooled Analysis of the SAINT I and II Trials

Stroke (1970), 2008-06, Vol.39 (6), p.1751-1758

2008

Volltextzugriff (PDF)

CN4 Patient-Reported Outcomes from the Phase 3, Randomized Study of Acalabrutinib with or without Obinutuzumab Versus Chlorambucil PLUS Obinutuzumab for Treatment-Naïve Chronic Lymphocytic Leukemia (ELEVATE-TN)

Value in health, 2021-06, Vol.24, p.S3-S4

2021

Volltextzugriff (PDF)

NXY-059 for Acute Ischemic Stroke

The New England journal of medicine, 2006-02, Vol.354 (6), p.588-600

2006

Volltextzugriff (PDF)

341TiP Phase 3 study of durvalumab (MEDI4736) alone or in combination with tremelimumab versus standard of care (SoC) in platinum-resistant recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): EAGLE

Annals of oncology, 2015-12, Vol.26, p.ix93-ix93

2015

Volltextzugriff (PDF)

Comparison of Methods for Detection of Fulvestrant-Induced Changes in Breast Tumor Estrogen and Progesterone Receptor Expression in a Neoadjuvant Trial (NEWEST)

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.1087-1087

2009

Volltextzugriff (PDF)

Comparison of methods for detection of fulvestrant-induced changes in breast tumor estrogen and progesterone receptor expression in a neoadjuvant trial (NEWEST)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e11602-e11602

2009

Volltextzugriff (PDF)

The potential of circulating microRNA (miRNA) levels as a biomarker in drug development: An analysis of tumor-serum samples from patients on a phase I trial of saracatinib-paclitaxel (P)-carboplatin (C)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.10548-10548

2011

Volltextzugriff (PDF)

Serosurvey and factors associated with Leishmania donovani infection in febrile HIV infected individuals attending Abuja Teaching Hospital, Nigeria

Medical journal of Zambia, 2019-04, Vol.45 (4), p.216-225

2019

Volltextzugriff (PDF)

Serosurvey and factors associated with Leishmania Donovani infection in febrile HIV infected individuals attending Abuja Teaching Hospital, Nigeria

Medical journal of Zambia, 2019-04, Vol.45 (4), p.216-225

2019

Volltextzugriff (PDF)

Survey of malaria and anti-dengue virus IgG among febrile HIV-infected patients attending a tertiary hospital in Abuja, Nigeria

HIV/AIDS (Auckland), 2017-01, Vol.9, p.145-151

2017

Volltextzugriff (PDF)

Prevalence of vulvovaginal candidiasis among nonpregnant women attending a tertiary health care facility in Abuja, Nigeria

Research and reports in tropical medicine, 2015-01, Vol.6 (default), p.37-42

2015

Volltextzugriff (PDF)

Frequency of MNSs blood groups in south eastern Nigeria

East African medical journal, 1997-07, Vol.74 (7), p.442

1997

Volltextzugriff (PDF)

Estimation of stream discharge of ungauged basins using NRCS-CN and remote sensing methods: A case study of Okhuwan and Okhaihe catchments, Benin City, Edo State, Nigeria

International Journal of Water Resources and Environmental Engineering, 2021-08, Vol.13 (3), p.165-183

2021

Volltextzugriff (PDF)

Prevalence of Haemoparasites in Blood Donors; Calabar, Nigeria Perspective

Asian Journal of Biological Sciences, 2019-06, Vol.12 (3), p.385-395

2019

Volltextzugriff (PDF)

Assessment of climate variability and the determinants of rice productivity in Southeastern Nigeria

Yüzüncü Yıl Üniversitesi Tarım Bilimleri Dergisi, 2022-12, Vol.32 (4), p.805-824

2022

Volltextzugriff (PDF)

Stigmatization as Correlate of Disposition to Utilization of Hiv/Aids Services Among Students in Tertiary Institution in Calabar Metropolis

Global journal of educational research, 2013-07, Vol.12 (1)

2013

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Biological And Medical Sciences
(6)
Humans
(6)
Female
(5)
General & Internal Medicine
(5)
Male
(5)
Medical Sciences
(5)
Medicine, General & Internal
(5)
Adult
(3)
Aged
(3)
Brain Ischemia - Drug Therapy
(3)
Double-Blind Method
(3)
Drug Therapy
(3)
Epidemiology
(3)
Middle Aged
(3)
Neurology
(3)
Stroke - Drug Therapy
(3)
Vascular Diseases And Vascular Malformations Of The Nervous System
(3)
Acute Disease
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Implications of SARS-CoV-2 genetic diversity and mutations on pathogenicity of the COVID-19 and biomedical interventions

P667: LONG‐TERM EFFICACY OF ACALABRUTINIB‐BASED REGIMENS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND HIGHER‐RISK GENOMIC FEATURES: POOLED ANALYSIS OF CLINICAL TRIAL DATA

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours

Type 1 diabetes mellitus and enterovirus linkage: search for associated etiopathology

The interplay between environmental factors, vector competence and vaccine immunodynamics as possible explanation of the 2019 yellow fever re-emergence in Nigeria

NXY-059 for the Treatment of Acute Ischemic Stroke

1748P 4-factor model to predict response and survival benefit with durvalumab (D) in previously treated metastatic urinary tract carcinoma (mUTC)

P4.11D.01 TRITON: Tremelimumab + Durvalumab + Chemotherapy (CT) vs Pembrolizumab + CT in mNSCLC with STK11, KEAP1 and/or KRAS Mutations

P1.01-108 PACIFIC-6: A Phase II Study of Durvalumab Following Sequential Chemoradiotherapy in Patients with Stage III, Unresectable NSCLC

NXY-059 for the Treatment of Acute Stroke : Pooled Analysis of the SAINT I and II Trials

CN4 Patient-Reported Outcomes from the Phase 3, Randomized Study of Acalabrutinib with or without Obinutuzumab Versus Chlorambucil PLUS Obinutuzumab for Treatment-Naïve Chronic Lymphocytic Leukemia (ELEVATE-TN)

NXY-059 for Acute Ischemic Stroke

341TiP Phase 3 study of durvalumab (MEDI4736) alone or in combination with tremelimumab versus standard of care (SoC) in platinum-resistant recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): EAGLE

Comparison of Methods for Detection of Fulvestrant-Induced Changes in Breast Tumor Estrogen and Progesterone Receptor Expression in a Neoadjuvant Trial (NEWEST)

Comparison of methods for detection of fulvestrant-induced changes in breast tumor estrogen and progesterone receptor expression in a neoadjuvant trial (NEWEST)

The potential of circulating microRNA (miRNA) levels as a biomarker in drug development: An analysis of tumor-serum samples from patients on a phase I trial of saracatinib-paclitaxel (P)-carboplatin (C)

Serosurvey and factors associated with Leishmania donovani infection in febrile HIV infected individuals attending Abuja Teaching Hospital, Nigeria

Serosurvey and factors associated with Leishmania Donovani infection in febrile HIV infected individuals attending Abuja Teaching Hospital, Nigeria

Survey of malaria and anti-dengue virus IgG among febrile HIV-infected patients attending a tertiary hospital in Abuja, Nigeria

Prevalence of vulvovaginal candidiasis among nonpregnant women attending a tertiary health care facility in Abuja, Nigeria

Frequency of MNSs blood groups in south eastern Nigeria

Estimation of stream discharge of ungauged basins using NRCS-CN and remote sensing methods: A case study of Okhuwan and Okhaihe catchments, Benin City, Edo State, Nigeria

Prevalence of Haemoparasites in Blood Donors; Calabar, Nigeria Perspective

Assessment of climate variability and the determinants of rice productivity in Southeastern Nigeria

Stigmatization as Correlate of Disposition to Utilization of Hiv/Aids Services Among Students in Tertiary Institution in Calabar Metropolis

Suchergebnisse filtern